Actively Recruiting
Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion
Led by Women's Hospital School Of Medicine Zhejiang University · Updated on 2025-08-28
200
Participants Needed
1
Research Sites
85 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Induced abortion is a common method to terminate pregnancy, but during the operation, it is necessary to dilate the cervix and aspirate the uterine cavity. Repeated induced abortions may increase the risk of uterine damage, leading to cervical stenosis or intrauterine adhesions, thinning of the endometrium, which may affect the implantation of fertilized eggs and the development of embryos, and ultimately may lead to infertility or miscarriage. This study aims to explore the effects of combined estrogen and progesterone on endometrial repair and ovarian function recovery after induced abortion.
CONDITIONS
Official Title
Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 years old (inclusive) and 40 years old (inclusive)
- Body Mass Index (BMI) ranging from 18.5Kg/8 to 23.9Kg/8
- Experienced at least 2 abortions or had a missed abortion
- Confirmed gestational age of no more than 10 weeks, and the ultrasonic examination within three days prior to the surgery shows a gestational sac (average of three diameters) of at least 1.0cm, with an embryo length of no more than 3.0cm
- Normal preoperative examination results as per the "Clinical Diagnosis and Treatment Guidelines and Technical Operation Standards: Family Planning Volume (2017 Revision)"
- Capable of regular follow-ups and willing to sign the informed consent form.
You will not qualify if you...
- Individuals with contraindications to estrogen and progesterone therapy
- History of uterine adhesions confirmed by hysteroscopy, or a history of uterine cavity surgery or uterine malformation correction
- Subjects who require placement of an intrauterine device or administration of oral contraceptives or subcutaneous implants after the procedure
- Individuals with mental status or cognitive function abnormalities who are unable to cooperate with the treatment process
- Subjects who, in the opinion of the investigator, have potential risks or any other factors that may interfere with the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Women's Hospital School Of Medicine Zhejiang University
Hangzhou, Zhejiang, China, 310006
Actively Recruiting
Research Team
X
Xiuxiu Jiang, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here